Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination
Our case highlights leukocytoclastic vasculitis as a potential side effect of the elasomeran COVID-19 vaccine. As the elasomeran vaccine becomes more widely available to the public, cutaneous reactions should be noted and looked for as potential side effects of the vaccine. Our patient had a history...
Saved in:
Main Authors: | Jarett J. Casale (Author), Mikél E. Muse (Author), Tara J. Snow (Author), Karen P. Gould (Author), Natalie D. Depcik-Smith (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous leukocytoclastic vasculitis following COVID‐19 vaccination
by: Manuel Zoppi, et al.
Published: (2023) -
Reverse koebner phenomenon in leukocytoclastic vasculitis
by: S Yadav, et al.
Published: (2011) -
Leukocytoclastic vasculitis due to thalidomide
by: Asude Kara, et al.
Published: (2017) -
A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration
by: Hana I. Nazir, et al.
Published: (2023) -
Cutaneous leukocytoclastic vasculitis associated with erlotinib
by: Takahiro Sawada, et al.
Published: (2016)